Upload
marilyn-briggs
View
219
Download
2
Tags:
Embed Size (px)
Citation preview
Module #2http://www.growthhouse.org/stanford
END-OF-LIFE CARE:Module 2
Pain Management
Module #2http://www.growthhouse.org/stanford
Case of Mrs. Dolores Long
Mrs. Dolores Long is a 70-year old widowed African American female who was recently diagnosed with lung carcinoma and metastasis to bone. She is being admitted to the hospital for a round of chemotherapy.A medical resident performs the admission H&P. Mrs. Long denies any symptoms. Physical examination is unremarkable. Mental status exam is significant for flat affect and poor eye contact. The resident finishes the exam and leaves the room. Mrs. Long’s daughter steps outside with the resident and explains that her mother has complained of severe pain and has become sedentary and withdrawn. She has refused the acetaminophen with codeine that was prescribed because she doesn’t want to “get hooked,” and the pills don’t help anyway.The resident is surprised, as Mrs. Long did not appear to be in pain. He explains that “nothing more can be done” for the pain, as strong narcotics like morphine might cause her to stop breathing and NSAIDs like ibuprofen could cause GI bleeding. However, psychiatry will be consulted to evaluate her depression.
Module #2http://www.growthhouse.org/stanford
Learning Objectives
Recognize and address barriers to effective EOL pain care
Develop a better understanding of attitudes and beliefs about pain management
Improve your knowledge and skills in assessing and treating pain
Incorporate this content into your clinical teaching
Module #2http://www.growthhouse.org/stanford
Outline of Module
Background
Barriers to treating pain
Pain Assessment
Non-pharmacologic treatment approaches
Break
Pharmacologic strategies
Pain medications
Application exercise
Summary and goals
Module #2http://www.growthhouse.org/stanford
Pain in the Hospitalized Seriously Ill
50% of conscious patients were in moderate to severe pain at least half the time in the three days prior to death
SUPPORT Study (1995), N = 9105 patients
Module #2http://www.growthhouse.org/stanford
Pain in Nursing Home Patients
• 30% reported daily pain• 26% of these patients received no analgesia• Only 26% of them received strong opioids
What predicted inadequate pain management?• Advanced age: >85 years old• Poor cognitive function• Minority status
Bernabei (1998), N = 13,625 cancer patients
Module #2http://www.growthhouse.org/stanford
Pain in Outpatients
• 67% outpatients with metastatic CA were in pain• 42% of those not given adequate analgesic therapy
What predicted inadequate pain management?• Discrepancy between patient and MD assessment of
pain• Advanced age: >70 years old• Female• Better performance status• Minorities
Cleeland (1994), N = 1308
Module #2http://www.growthhouse.org/stanford
Pain in 103 Children who Died of Cancer or its Complications
• 89% died while suffering pain or other symptoms
• Of those whose pain was treated, treatment was successful in only 27%
Wolfe, 2000
Module #2http://www.growthhouse.org/stanford
Brainstorm
What makes pain so difficult to treat?
Module #2http://www.growthhouse.org/stanford
Six Major Barriers to Adequate Pain Care
• Myth: That addiction is a common result of treating pain with opioids
• Regulatory and legal concerns• System barriers• Deficits in knowledge and education• Fear of side effects• Assessment challenges
Module #2http://www.growthhouse.org/stanford
Definitions
• Addiction: Psychological dependence on a drug. Drug-seeking behavior despite adverse consequences
• Physical Dependence: Development of physical withdrawal reaction upon discontinuation or antagonism of a drug
• Tolerance: Need to increase amount of drug to obtain the same effect
• Pseudoaddiction: Behavior suggestive of addiction occurring as a result of undertreated pain
Module #2http://www.growthhouse.org/stanford
Barrier #1: The Myth of Addiction
• Addiction differs from chemical dependence, tolerance, and pseudoaddiction
• Increased use of opioid analgesics for pain does not appear to contribute to increases in opioid abuse (Joranson, 2000)
• Fears are exaggerated due to referral bias• Pseudoaddiction complicates the picture• Increased opioid requirement is usually related
to progression of disease, not tolerance
Module #2http://www.growthhouse.org/stanford
Barrier #2: Regulatory and Legal Concerns
• Physicians are wary of prescribing controlled substances for fear of criminal and/or licensing sanctions– Risk is very low if indication and response are
properly documented
• Regulatory policies that control opioids get in the way– Triplicates– Renewal policies
Module #2http://www.growthhouse.org/stanford
#3 System Barriers
• Lack of systemic use of practice guidelines• Pain management historically has not been
incorporated into quality management structure• Many institutions still lack pain and/or palliative
care services
Module #2http://www.growthhouse.org/stanford
Barrier #4: Deficits in Knowledge and Education
• In patients, families, physicians, and other health care professionals
• Pain management is still rarely addressed in medical school curricula
• It is rarely included in textbooks– < 2% medical textbook content (Rabow, 2000)– < 5% nursing textbook pages (Ferrell, 1999)
• Physicians lack awareness of their own knowledge deficits in pain management
Module #2http://www.growthhouse.org/stanford
Barrier #5: Bad Side Effects of Opioids - Key Points
• Pain is a partial antagonist to respiratory depression and CNS sedation
• Respiratory depression, sedation, and N&V relate more to changing blood serum levels of opioids than the steady state dose
• Pain management and constipation relate to steady state dosing, not the rising blood opioid level– Treat prophylactically and continually
Module #2http://www.growthhouse.org/stanford
Barrier #6: Assessment Challenges
• Health care professionals are more comfortable measuring objective data
• We lack a scanner that is more accurate than patient report
Module #2http://www.growthhouse.org/stanford
Assessment of Pain:Key Dimensions
Mechanism• Neuropathic pain
Abnormal state of central or peripheral nervous system gives rise to pain
• Nociceptive pain
Nerves responding appropriately to a painful stimulus
Timeline• Acute• Chronic
Module #2http://www.growthhouse.org/stanford
We are All ‘Color-blind’ to Chronic Pain
Patients’ assessments
correlated with those of:
0-2
Little or no pain
3-6
Moderate pain
7-10
Severe pain
Nurse 82% 51% 7%
House Officer 66% 26% 21%
Onc Fellow 70% 29% 27%
Caregiver 79% 37% 13%
Module #2http://www.growthhouse.org/stanford
A Tool to Help Assess Pain
N - Number of pains?
O - Origin/causes?
P - Palliates, potentiates?
Q - Quality?
R - Radiation?
S - Severity, suffering?
T - Timing, trend?
Module #2http://www.growthhouse.org/stanford
Neuropathic Pain
• Origin: – Nerve damage
• Palliates/potentiates: – Set off by unusual stimuli, light touch, wind on skin,
shaving (trigeminal neuralgia)
• Quality: – Electric, burning, tingling, pins & needles, shooting
(system isn’t working right)
• Radiation: – Nerve-related pattern
Module #2http://www.growthhouse.org/stanford
Nociceptive Pain
• Origin:– Tissue damage
• Palliates/potentiates:– Worse with stress, pressure– Responds better to opioids, NSAIDs
• Quality:– Sharp, dull, stabbing, pressure, ache, throbbing
• Radiation:– Occasionally radiates (less well-defined), but not
along an obvious nerve distribution
Module #2http://www.growthhouse.org/stanford
Visual Analog Scale
1-3 Tolerable
4-6 Change therapy soon
7-10 Emergency SOS - change therapy now
Module #2http://www.growthhouse.org/stanford
Suffering
“A state of severe distress associated with events that threaten the intactness of the person”
Cassell,1982
• Subjective: No way to measure it• Significantly diminishes quality of life
Module #2http://www.growthhouse.org/stanford
Back to the Mnemonic
• Timing:– When the pain occurs or with certain activities
• Trend:– Whether a pain is getting better or worse over time
Module #2http://www.growthhouse.org/stanford
Total Pain
P - Physical pain
A - Affective distress
I - Interpersonal distress
N - Non-acceptance, or spiritual distress
Module #2http://www.growthhouse.org/stanford
Discussion
Strategies for alleviating pain:
Non-pharmacologic options
Module #2http://www.growthhouse.org/stanford
Non-pharmacologic Approaches to Pain
Behavioral therapy
Spiritual counseling
Physical therapy
Psychotherapy
Splinting
Surgical correction
Cold packs
Meditation
Support groups
Radiation therapy
Acupuncture
Hypnosis
Cultural healing rituals
Heat packs
Prayer
Community resources
And others…
Module #2http://www.growthhouse.org/stanford
General Principles for Alleviating Pain
• Assess with NOPQRST• Identify types(s) and location(s) of pain• Correct underlying cause, if possible• Consider special circumstances
– Avoid specific toxicities– Look for ‘two-fers’– Medication routes– Self-administered or by others
Module #2http://www.growthhouse.org/stanford
Pattern MatchingS
ever
ity
Time
Module #2http://www.growthhouse.org/stanford
How Would You Treat the Acute Pain Pattern?
Sev
erity
Time
Module #2http://www.growthhouse.org/stanford
What Would a Chronic Pain Pattern Look Like?
Sev
erity
Time
Module #2http://www.growthhouse.org/stanford
Treating Chronic Pain
Basal pain medicine plus a different therapy for spikes:
– Predictable spikes - Short-acting agent prior to event– Unpredictable spikes - Short-acting agent readily
available
Module #2http://www.growthhouse.org/stanford
Case Discussion
Chronic pain escalating at night - Why?
Module #2http://www.growthhouse.org/stanford
Brainstorm
How might we treat Mrs. Long’s pain?
Module #2http://www.growthhouse.org/stanford
Neuropathic Pain Medications
• Opioids, NSAIDs somewhat less effective• Classes of agents:
– Tricyclic for dysesthetic pain– Anticonvulsants for shooting pain– Steroids to decrease peri-tumor edema
• ‘Two-fers’ important in choice of agent(s)• Generally harder to treat than nociceptive pain
– More likely to need specialist expertise
Module #2http://www.growthhouse.org/stanford
NSAIDs
• May be more effective than opioids with certain
forms of pain• Not necessarily less toxic than opioids• Toxicity can be minimized• For basal pain relief, consider longer-acting
agent for ease of dosing
Module #2http://www.growthhouse.org/stanford
Combination Drugs
• Advantages:– Aspirin or acetaminophen may act as co-analgesic– Lower level regulatory control
• Disadvantages:– Available in short-acting formulations only– ‘Combo wall’
Module #2http://www.growthhouse.org/stanford
Acetaminophen With Codeine
• Advantages:– Low regulatory control– Inexpensive– Widely available
• Disadvantages:– 10% cannot convert codeine to morphine– Many drugs interfere with conversion
Module #2http://www.growthhouse.org/stanford
Acetaminophen with Oxycodone, Hydrocodone
• Oxycodone combination contains 325 mg acetaminophen
• Hydrocodone combination contains 500 mg acetaminophen
• No clear advantage between the two• Dose equivalence is poorly established for
hydrocodone
Module #2http://www.growthhouse.org/stanford
Case Discussion
• Why didn’t Mrs. Long respond to acetaminophen with codeine?
Module #2http://www.growthhouse.org/stanford
Opioids
• Morphine• Oxycodone• Hydromorphone• Transdermal fentanyl
Module #2http://www.growthhouse.org/stanford
Principles of Opioid Use
• No ceiling effect• Dose to pain relief without side effects• Give orally when possible• Sub-cutaneous administration is basically
equivalent to intravenous (and preferable)• Treat constipation prophylactically
Module #2http://www.growthhouse.org/stanford
Morphine
• Advantages:– Inexpensive– Routes: PO, PR, IV, SC, lingual
• Disadvantages:– Histamine release– Side effects, toxicity in high dose/renal failure– ‘Psychological allergy’
• Formulation:Long-acting ‘wax matrix,’ short-acting liquid, tab
Module #2http://www.growthhouse.org/stanford
Standard Starting Dose
• For opioid-naïve, 5-10 mg PO q4 PRN• After getting an idea of the 24-hour dose, go
to long-acting• Or start with 15 mg q12 long-acting• There is no ceiling effect
Module #2http://www.growthhouse.org/stanford
Oxycodone
• Advantages:– Good alternative to morphine– Available PO: long-acting (q8-12) or short-acting– ? Less CNS alteration than with morphine– ? Less histamine release
• Disadvantages:– More expensive than morphine– No parenteral form available in the U.S.A.
Module #2http://www.growthhouse.org/stanford
Hydromorphone
• Advantages:– Available PO, IV, SC– Good alternative to morphine for parenteral use– No known toxic metabolites– Long-acting oral form now available
Module #2http://www.growthhouse.org/stanford
Transdermal Fentanyl
• Advantages– Non-enteral administration– Change q72h– Steady blood levels
• Disadvantages– Local skin problems– Delayed onset and offset– Cumbersome to titrate (only q72h)– 20% of people need it changed q48h– Expensive
Module #2http://www.growthhouse.org/stanford
Question
What were the general principles of opioid use we mentioned earlier?
Module #2http://www.growthhouse.org/stanford
Case Discussion
What do you suggest to help alleviate Mrs. Long’s pain?
What more do we need to know?
Module #2http://www.growthhouse.org/stanford
Case Discussion, Continued
Mrs. Long has bony pain in the hip that seems to be nociceptive
• What might this pain pattern look like?• What should we treat her with, and why?
Module #2http://www.growthhouse.org/stanford
Opioid Conversion
• This is a crucial skill in ELC• Traditionally, it was viewed as a task• It would be more correct to think of it as a
process
Module #2http://www.growthhouse.org/stanford
Using Opioid Conversion Tables
• Calculate 24h equivalent of old drug• Convert to 24h equivalent of new drug or route• Calculate new dosing interval• Divide 24h dose by new dosing interval• Round off this value• Account for residual drug
Module #2http://www.growthhouse.org/stanford
Application
• Mrs. Long is admitted to the hospital and can no longer take pills
• She has been taking sustained action oral morphine 60mg q12
• Her family just managed to get her to take her last dose 2 hours ago
• Her pain is well controlled• You want to start her on a SC infusion of
morphine
Module #2http://www.growthhouse.org/stanford
Warnings
• Most narcotic conversion charts are based on peak drug levels
• Increase on percentage basis not dosage: 25-50% per each 24 hours
• Dose to comfort or side effects (monitor)
Module #2http://www.growthhouse.org/stanford
Opioids May Differ
Opioids may differ from each other significantly in:
• Mechanism of action• Degree of cross-tolerance
Module #2http://www.growthhouse.org/stanford
Two Principles
In the conversion process:
• For the new drug, use basal doses initially• Be relatively liberal in your use of
breakthrough/short-acting doses
Module #2http://www.growthhouse.org/stanford
Learning Objectives
Recognize and address barriers to effective pain care
Develop a better understanding of attitudes and beliefs about pain management
Improve your knowledge and skills in assessing and treating pain
Incorporate this content into your clinical teaching
.